- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01615289
Neural Effects of Green Tea Extract on Dorsolateral Prefrontal Cortex
Study Overview
Status
Conditions
Intervention / Treatment
- Dietary supplement: Single intragastric instillation of 250 ml green tea extract
- Dietary supplement: Single intragastric instillation of 500 ml green tea extract
- Dietary supplement: Single intragastric instillation of 250 ml control solution
- Dietary supplement: Single intragastric instillation of 500 ml control solution
Detailed Description
As functional neuroimaging provides a means of examining how green tea extract acts on the brain, we used functional magnetic resonance imaging (fMRI) to study healthy volunteers while they performed a working memory task following intra-gastric administration of either 250 ml or 500 ml Rivella green® (RG), a milk whey based green tea extract containing soft drink, or Rivella blue® (RB), a milk whey based soft drink without green tea extract as sham condition in a double-blind, controlled design. Based on the literature on pharmacological and behavioural effects of green tea, we hypothesized - a priori - that green tea extract would subtly modulate the engagement of the dorsolateral prefrontal cortex (DLPFC), a brain region critically involved in many cognitive functions such as working memory processing.
A double-blind, controlled, within-subject study with counterbalanced order of substance administration using an established protocol (6-8) was conducted over 4 sessions (250 ml or 500 ml Rivella green® (including green tea extract; RG), 250 or 500 ml Rivella blue® (RB). Each participant was scanned four times with a one-week interval between scans. The order of substance administration across sessions was counterbalanced across subjects, such that equal numbers followed each substance sequence.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Basel, Switzerland, CH-4031
- University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- right-handed healthy males, no drugs, non-smoking
Exclusion Criteria:
- drug abuse, smoker, left-handed
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Green tea extract, 250 ml
Single intragastric instillation of 250 ml green tea extract
|
Intragastric instillation by feeding tube
|
|
Active Comparator: Green tea extract, 500 ml
Intragastric instillation of 500 ml green tea extract solution
|
Intragastric instillation by feeding tube
|
|
Placebo Comparator: Control solution, 250 ml
Intragastric instillation of 250 ml control solution
|
Intragastric instillation by feeding tube
|
|
Placebo Comparator: Control solution, 500 ml
Single intragastric instillation of 500 ml control solution
|
Intragastric instillation by feeding tube
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Functional magnetic resonance imaging (fMRI) in healthy volunteers while they performed a working memory task
Time Frame: 0 and 45 min
|
Whole brain analysis with a cluster-level threshold was followed by an a priori defined region of interest analysis of the dorsolateral prefrontal cortex including a cluster-level threshold and family-wise error adjustment for multiple comparisons.
|
0 and 45 min
|
Collaborators and Investigators
Investigators
- Principal Investigator: Christoph Beglinger, MD, University Hospital, Basel, Switzerland
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EKBB 32/09
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Exploratory Behavior
-
University Hospital, Basel, SwitzerlandCompletedExploratory BehaviorSwitzerland
-
Harvard UniversityCompletedIntention | Exploratory BehaviorUnited States
-
University Hospital, Basel, SwitzerlandCompleted
-
University Hospital, Basel, SwitzerlandCompletedExploratory BehaviorSwitzerland
-
University Hospital, Basel, SwitzerlandCompletedExploratory Behavior
-
Laboratorios Casen-Fleet S.L.U.Apices Soluciones S.L.; Trial Form Support S.L.CompletedSubjects Undergoing a Complete Exploratory Diagnostic Colonoscopy for the First Time.Spain
-
Shanghai 6th People's HospitalUnknownExploratory Study
-
Guangdong Provincial Hospital of Traditional Chinese...UnknownStage IV Gastric Cancer With Metastasis | Hyperthermic Intraperitoneal Chemotherapy | Exploratory BehaviorChina
-
University of SaskatchewanGovernment of Canada; Vaccine Formulation Institute (VFI); Government of Saskatchewan and other collaboratorsCompletedDouble Vaccinated for COVID-19 (For Phase 1 of the Study) | Acute Respiratory Syndrome Coronavirus 2 (For Phase 2 Exploratory Group)Canada
-
Lina ZhangNot yet recruitingEating Behavior | Dietary BehaviorChina
Clinical Trials on Single intragastric instillation of 250 ml green tea extract
-
University Hospital, Basel, SwitzerlandCompleted
-
Martin-Luther-Universität Halle-WittenbergUniversity of Ulm; Deutsche Krebshilfe e.V., Bonn (Germany); KKS NetzwerkCompletedColorectal Serrated Adenomas | Colorectal Tubular Adenomas | Colorectal Villous Adenomas | Colorectal Tubulovillous AdenomasGermany
-
Taipei City HospitalNational Science Council, Taiwan; Taipei Hospital, TaiwanCompleted
-
University Hospital, Basel, SwitzerlandCompletedExploratory BehaviorSwitzerland
-
Dartmouth-Hitchcock Medical CenterCompleted
-
Anglia Ruskin UniversityCompletedOverweight and Obesity | Fat BurnUnited Kingdom
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
University of North Carolina, Chapel HillNational Institutes of Health (NIH); National Center for Complementary and...CompletedChronic Hepatitis C | Oxidative StressUnited States
-
Sanjay Gupta PhDTerminatedStage I Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Cairo UniversityCompleted